Literature DB >> 9184386

High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.

J O'Donnell1, E G Tuddenham, R Manning, G Kemball-Cook, D Johnson, M Laffan.   

Abstract

A recent report from the Leiden Thrombophilia Survey identified high factor VIII activity levels as an independent risk factor for venous thromboembolism in a population survey. As the study measure for factor VIII was a one-stage coagulation assay, and since markers for the acute phase reaction were not assessed, it remained uncertain whether the increase was due to a constitutional increased rate of synthesis, to circulating activated factor VIII, or to an acute phase response. We added factor VIII activity assay (FVIII:C), factor VIII antigen (FVIII:Ag), vWF antigen (vWF:Ag), ABO blood group, fibrinogen and C-reactive protein to our routine thrombophilia screen of patients referred because of unexplained thromboembolism. Elevated FVIII:C (> 1.5 iu/ml) emerged as the single commonest abnormality detected in 25.4% of a group of 260 such patients. FVIII:C and FVIII:Ag were highly correlated (p = 0.003), showing that this represented a true increase in FVIII. In 4 of 46 patients this was clearly attributable to an acute phase reaction. Eleven others showed minor elevation of ESR and one of CRP. Neither FVIII:C or FVIII:Ag showed significant correlation with fibrinogen, ESR or C-reactive protein by non parametric analysis. Although there was an excess of patients with B blood group (known to be associated with FVIII:C levels which are approximately 15% higher than those in blood group O), this could not account for the marked elevation of factor VIII observed in these patients. We conclude that factor VIII activity assay should be a routine part of thrombophilia screening. We are investigating the cause of the increased synthesis, initially by means of family studies and linkage analysis with polymorphic markers of the FVIII locus. We postulate that it may be constitutive in some cases and in others an abnormal or exaggerated response to inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184386

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

1.  Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities.

Authors:  Thomas L Abell; Archana Kedar; Abigail Stocker; Karen Beatty; Lindsay McElmurray; Michael Hughes; Hani Rashed; William Kennedy; Gwen Wendelschafer-Crabb; Xiu Yang; Mostafa Fraig; Leila Gobejishvili; Endashaw Omer; Ed Miller; Michael Griswold; Christina Pinkston
Journal:  Dig Dis Sci       Date:  2020-04-23       Impact factor: 3.199

2.  Elevated factor VIII increases the risk of cerebral venous thrombosis: a case-control study.

Authors:  Loes Vecht; Susanna M Zuurbier; Joost C M Meijers; Jonathan M Coutinho
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

Review 3.  Factoring in Factor VIII With Acute Ischemic Stroke.

Authors:  James E Siegler; Alyana Samai; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2015-02-10       Impact factor: 2.389

Review 4.  Genetics and pulmonary medicine. 4. Pulmonary embolism.

Authors:  M Laffan
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

5.  Lack of association of common polymorphism of LRP1 gene with myocardial infarction in a Chinese Han population.

Authors:  Honggang Ren; Tao Guo; Huafang Wang; Chunyan Sun; Xiaoping Zhang; Heng Mei; Yu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 6.  Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.

Authors:  Antonio Girolami; Raffaella Scandellari; Ezio Zanon; Roberto Sartori; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

7.  Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship?

Authors:  M Francesca Monn; Xuan Hui; Brandyn D Lau; Michael Streiff; Elliott R Haut; Elizabeth C Wick; Jonathan E Efron; Susan L Gearhart
Journal:  Dis Colon Rectum       Date:  2014-04       Impact factor: 4.585

8.  Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Maeve P Crowley; Maeve P Crowely; Shane Quinn; Eoin Coleman; Joseph A Eustace; Oonagh M Gilligan; Susan I O'Shea; Susan I O Shea
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 9.  Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?

Authors:  Shan Zhou; Ian Welsby
Journal:  World J Cardiol       Date:  2014-09-26

10.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.